Denali Therapeutics Inc. (DNLI)
Denali Therapeutics Inc. (DNLI) has a 34-report earnings history dating back to Mar 19, 2018. Its average absolute post-earnings move is ±5.03%, and 50.0% of those reactions were positive. Its largest post-earnings gain was +38.25% (Feb 27, 2024) and its largest decline was -10.97% (Feb 27, 2025). The next earnings report is predicted for 2026-08-06 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
34
Avg Abs. Movement
±5.03%
Positive %
50.0%
Negative %
50.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☽ POST | $20.25 | $20.25 | $19.71 | 77,391 | -0.61% | open_in_new |
| Feb 26, 2026 | ☽ POST | $22.20 | $22.39 | $21.42 | 1,655,500 | -1.12% | open_in_new |
| Nov 06, 2025 | ☽ POST | $14.82 | $15.10 | $14.41 | 1,181,400 | +4.23% | open_in_new |
| Aug 11, 2025 | ☽ POST | $13.96 | $14.11 | $13.92 | 1,294,500 | -5.03% | open_in_new |
| May 06, 2025 | ☽ POST | $15.69 | $16.16 | $13.97 | 2,093,900 | +2.51% | open_in_new |
| Feb 27, 2025 | ☽ POST | $19.13 | $19.52 | $18.60 | 816,100 | -10.97% | open_in_new |
| Nov 06, 2024 | ☽ POST | $28.98 | $29.60 | $29.55 | 1,031,200 | +0.17% | open_in_new |
| Aug 01, 2024 | ☀ PRE | $23.80 | $24.57 | $23.33 | 1,410,900 | -4.27% | open_in_new |
| May 07, 2024 | ☽ POST | $17.37 | $17.42 | $16.85 | 1,099,300 | +12.17% | open_in_new |
| Feb 27, 2024 | ☀ PRE | $19.94 | $23.52 | $23.35 | 5,089,800 | +38.25% | open_in_new |
| Nov 07, 2023 | ☽ POST | $20.80 | $21.23 | $21.23 | 748,900 | -4.95% | open_in_new |
| Aug 08, 2023 | ☽ POST | $25.97 | $26.83 | $25.83 | 727,000 | -4.26% | open_in_new |
| May 08, 2023 | ☽ POST | $26.46 | $26.66 | $26.56 | 394,700 | +2.86% | open_in_new |
| Feb 27, 2023 | ☽ POST | $25.97 | $26.98 | $26.81 | 897,700 | +1.27% | open_in_new |
| Nov 03, 2022 | ☽ POST | $30.46 | $31.46 | $30.63 | 524,300 | -7.54% | open_in_new |
| Aug 08, 2022 | ☽ POST | $36.12 | $38.70 | $37.25 | 852,100 | +0.43% | open_in_new |
| May 05, 2022 | ☽ POST | $26.17 | $26.17 | $23.97 | 567,100 | -3.84% | open_in_new |
| Feb 28, 2022 | ☽ POST | $32.86 | $33.55 | $32.56 | 537,200 | -1.41% | open_in_new |
| Nov 04, 2021 | ☽ POST | $53.08 | $53.73 | $52.68 | 360,400 | +4.44% | open_in_new |
| Aug 04, 2021 | ☽ POST | $50.93 | $53.09 | $50.88 | 321,400 | +4.03% | open_in_new |
| May 03, 2021 | ☀ PRE | $60.22 | $61.00 | $58.31 | 479,900 | -3.52% | open_in_new |
| Feb 25, 2021 | ☽ POST | $65.76 | $67.66 | $63.00 | 561,000 | +13.97% | open_in_new |
| Nov 05, 2020 | ☽ POST | $51.40 | $52.69 | $52.27 | 676,200 | +3.77% | open_in_new |
| Aug 07, 2020 | ☽ POST | $32.58 | $34.88 | $31.61 | 1,365,400 | +6.26% | open_in_new |
| May 07, 2020 | ☽ POST | $25.82 | $25.88 | $23.86 | 499,200 | +0.13% | open_in_new |
| Feb 27, 2020 | ☽ POST | $21.17 | $21.40 | $19.02 | 1,105,200 | +3.94% | open_in_new |
| Nov 06, 2019 | ☽ POST | $16.57 | $16.82 | $16.26 | 263,800 | -4.55% | open_in_new |
| Aug 06, 2019 | ☽ POST | $18.93 | $19.32 | $19.16 | 299,800 | -1.51% | open_in_new |
| May 08, 2019 | ☽ POST | $23.49 | $23.90 | $23.53 | 231,100 | -4.89% | open_in_new |
| Mar 12, 2019 | ☀ PRE | $22.26 | $23.09 | $22.20 | 441,600 | +1.79% | open_in_new |
| Nov 08, 2018 | ☽ POST | $17.33 | $17.56 | $17.35 | 115,600 | -3.86% | open_in_new |
| Aug 09, 2018 | ☽ POST | $15.12 | $16.00 | $15.30 | 306,100 | -1.44% | open_in_new |
| May 11, 2018 | ☀ PRE | $20.43 | $20.43 | $19.44 | 305,500 | -5.17% | open_in_new |
| Mar 19, 2018 | ☀ PRE | $21.43 | $22.00 | $21.96 | 450,500 | +1.97% | open_in_new |
Earnings Count
34
Total earnings in dataset
Avg Abs. Movement
±5.03%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 8-K | 20260604 | open_in_new SEC.gov |
| 8-K | 20260522 | open_in_new SEC.gov |
Frequently asked about DNLI earnings
When does Denali Therapeutics Inc. report earnings next? expand_more
Denali Therapeutics Inc. (DNLI)'s next earnings date is approximate for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DNLI stock move after earnings? expand_more
Over 34 reports, DNLI has moved an average of ±5.03% the session after earnings, closing higher 50.0% of the time.
What was DNLI's biggest post-earnings move? expand_more
DNLI's largest post-earnings gain on record was +38.25% on Feb 27, 2024, and its largest decline was -10.97% on Feb 27, 2025.
Where can I find Denali Therapeutics Inc.'s SEC filings? expand_more
All of Denali Therapeutics Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right